skip to content

eLesor Investments version="1.1" id="Layer_1" xmlns="" xmlns:xlink="" x="0px" y="0px" viewBox="0 0 697.5 99.8" style="enable-background:new 0 0 697.5 99.8;" xml:space="preserve" aria-labelledby="title--mwlogoHeader desc--mwlogoHeader" role="img"> eLesor Site Logo A link that brings you back to the homepage.

Company Close Updates

Vertex Pharmaceuticals Inc. stock falls Tuesday, underperforms market

Company Logo

Terrence Horan

Referenced Symbols

Shares of Vertex Pharmaceuticals Inc. VRTX, -0.05% slid 1.42% to $214.85 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA, -0.24% rising 0.06% to 34,133.03 and the S&P 500 Index SPX, -0.39% falling 0.67% to 4,164.66. This was the stock's second consecutive day of losses. Vertex Pharmaceuticals Inc. closed $91.23 short of its 52-week high ($306.08), which the company reached on July 7th.

The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson JNJ, +0.42% rose 1.55% to $167.77, Merck & Co. Inc. MRK, +2.35% rose 0.01% to $75.99, and AbbVie Inc. ABBV, +1.01% fell 0.68% to $113.90. Trading volume (1.8 M) remained 30,821 below its 50-day average volume of 1.8 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Partner Center